LTF and infection: Early preclinical studies have shown that bovine lactoferrin is well tolerated by newborns and retains biological activity in the gut, and that administering bovine lactoferrin to very low birthweight infants protects against late sepsis and necrotizing enterocolitis resulting from various infections [58].